Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Ma, Xin-Liang

< Back

Profile

Xin-Liang Ma

Xin-Liang Ma, MD

Contact Dr. Ma

1025 Walnut Street
Suite 808
Philadelphia, PA 19107

(215) 955-4994
(215) 503-4458 fax

Medical School

The Fourth Military Medical University, China

Fellowship

Thomas Jefferson University

University Appointment

Professor of Emergency Medicine,
Professor of Medicine

Research & Clinical Interests

Protection of Myocardial Injury (ischemia. Reperfusion, diabetes)

Publications

Most Recent Peer-Reviewed Publications

  1. Mechanisms of adiponectin protection against diabetes-induced vascular endothelial injury
  2. C1q/TNF-related protein 3 (CTRP3) and 9 (CTRP9) concentrations are decreased in patients with heart failure and are associated with increased morbidity and mortality
  3. The role of NO-cGMP pathway inhibition in vascular endothelial-dependent smooth muscle relaxation disorder of AT1-AA positive rats: protective effects of adiponectin
  4. Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling
  5. Association of obstructive sleep apnea with C ardiovascular outcomes in patients with acute coronary syndrome
  6. Withaferin a prevents myocardial ischemia/reperfusion injury by upregulating AMP-activated protein kinase-dependent B-cell lymphoma2 signaling
  7. Active immunization using hand-push emulsification method increases the operator's risk of transcutaneous immunization
  8. Withaferin A inhibits apoptosis via activated Akt-mediated inhibition of oxidative stress
  9. The contribution of chronic intermittent hypoxia to OSAHS: From the perspective of serum extracellular microvesicle proteins
  10. Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis article
  11. PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes
  12. The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
  13. An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury
  14. Endothelial Cell-Derived Microparticles from Patients with Obstructive Sleep Apnea Hypoxia Syndrome and Coronary Artery Disease Increase Aortic Endothelial Cell Dysfunction
  15. C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways
  16. Restoring diabetes-induced autophagic flux arrest in ischemic/reperfused heart by ADIPOR (adiponectin receptor) activation involves both AMPK-dependent and AMPK-independent signaling
  17. Response by Du et al to letter regarding article, “Cardiac fibroblast-specific activating transcription factor 3 protects against heart failure by Suppressing MAP2K3-p38 signaling”
  18. Adiponectin improves coronary no-reflow injury by protecting the endothelium in rats with type 2 diabetes mellitus
  19. Danshen-Chuanxiong-Honghua ameliorates cerebral impairment and improves spatial cognitive deficits after transient focal ischemia and identification of active compounds
  20. MICU1 protects against myocardial ischemia/reperfusion injury and its control by the importer receptor Tom70
  21. Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification
  22. Mitochondrial Omi/HtrA2 Promotes Caspase Activation Through Cleavage of HAX-1 in Aging Heart
  23. Cardiac fibroblast-specific activating transcription factor 3 protects against heart failure by suppressing MAP2K3-p38 signaling
  24. Pharmacokinetic study of representative anti-oxidative compounds from Denshen-Chuanxiong-Honghua following oral administration in rats
  25. T-cadherin deficiency increases vascular vulnerability in T2DM through impaired NO bioactivity